比较餐用鳖甲与药典法鳖甲对肝纤维化的预防和治疗作用。
Compare the preventive and protective effects on hepatization fibrosis of Carapax trimycis.
影像学技术在诊断肝纤维化中的应用。
目的探讨肝纤维化组织学量化诊断方法。
Objective To discuss the histological quantitative method of hepatic fibrosis.
目的：研究肝乐康胶囊抗肝纤维化的作用。
Objective: To investigate the anti-hepatic fibrosis action of Ganlekang Capsule.
目的：评价不同方法对肝纤维化的诊断价值。
Objective: To evaluate the diagnostic values of different methods for liver fibrosis.
结论P PN对家兔肝纤维化有一定逆转作用。
Conclusion PPN has reversible effect on liver fibrosis in rabbit.
观察软肝化疒征丸干预肝纤维化的主要作用机制。
The main mechanism of the interfering effects of Ruanganhuazheng Pills (RP) on hepatic fibrosis was studied.
目的了解血清肝纤维化指标与临床及病理的关系。
Objective to study the relation of hepatic fibrosis indexes to clinic and pathology.
目的：研究牛磺酸对大鼠实验性肝纤维化的影响。
Objective: To study the effect of taurine on experimental hepatic fibrosis in rats.
目的：观察中药三甲降纤方抗肝纤维化的临床效果。
Objective: To observe the clinical effect of SJF in treating liver fibrosis.
非侵袭性方法用于肝纤维化评估：未来的窗口打开？
Noninvasive methods for the assessment of liver fibrosis: a window open on the future?
超声分级级别越高，血清肝纤维化4项指标含量越高。
The more advanced the ultrasonic scales of liver fibrosis, the higher level the 4 serum indicators.
对于肝纤维化，目前除了肝脏移植外，没有其它有效的治疗方法。
There are really no effective therapies for liver fibrosis-there is only transplantation.
观察疏肝清脂汤治疗混合性肝病肝纤维化的临床疗效。
To observe the clinical effect of Sugan Qingzhi Decoction on mixed liver disease fibrosis.
肝硬化是肝细胞坏死后，肝纤维化和肝细胞再生所致。
Ongoing liver damage with liver cell necrosis followed by fibrosis and hepatocyte regeneration results in cirrhosis.
目的构建大鼠肝纤维化模型，观察纤维化的病理进程。
Objective To build rat liver fibrosis model and observe its pathological course.
结论肝之福可保护肝脏，预防或缓解肝纤维化的形成。
CONCLUSION Ganzhifu can protect liver and prevent or alleviate the rats hepatic fibrosis.
红景天甙对肝纤维化大鼠肝组织ROCK表达的影响。
Effects of salidroside on expression of ROCK in rats with liver fibrosis.
目的探讨自身免疫性肝炎（AIH）肝纤维化的机制。
Objective To explore the mechanism of fibrosis in autoimmune hepatitis(AIH).
目的探讨卡托普利对早期肝炎肝硬化肝纤维化指标的影响。
Objective to explore the influence of captopril on liver fibrosis index during early-stage viral liver cirrhosis.
目的明确肝纤维化血清学指标对诊断肝纤维化的临床价值。
Objective To evaluate the clinical value of serum fibrosis index in the diagnosis of hepatic fibrosis.
这种情况可能导致肝炎，肝纤维化，肝硬化和肝功能衰竭。
The condition can lead to hepatitis, fibrosis, cirrhosis and liver failure.
目的研究肝星状细胞(HSC)与肝纤维化和肝硬化的关系。
Objective To investigate the relationship between hepatic fibrosis and hepatic stellate cell (HSC).
目的：观察血清层粘连蛋白（LN）对肝纤维化的诊断价值。
Objective:To investigate the diagnosis value of LN of serum to hepatofiberosis.
目的探讨当归根提取物治疗血吸虫性肝纤维化门脉高压症的效果。
Objective to study the treatment effects of angelica roots to portal hypertension of schistosomal liver fibrosis.
《国际肝病》：您认为维生素d在治疗肝纤维化患者的前景如何？
Hepatology Digest: What's your view on the future of vitamin D in the treatment of patients with liver fibrosis?
目的探讨超声衰减成像技术(uai)定量评估肝纤维化的可能性。
ObjectiveTo investigate the feasibility of quantitatively assessing hepatic fibrosis by ultrasonic tissue attenuation imaging (UAI).
这将在肝纤维化治疗上给予我们新的启发，并给我们提供检验新的治疗方法的平台。
This will give us new insights for the treatment for liver fibrosis, and it will give us the platform to test new treatments.
请您给我们介绍一下抗肝纤维化药物对于肝星状细胞的可能的作用机制？
Would you please give us a brief introduction on the possible strategies to target HSCs using anti-fibrotic agents?
方法对50例肝纤维化患者和患者住地附近非肝纤维化者作病例对照研究。
Methods By comparing the influential factors in 50 patients with hepatic fibrosis and those without who lived nearby.
应用推荐